APA

Hu Y., Chu K., Lavis N., Li X., Liang B., Liu S., Shao M., Shu J., Tabar C. & Samson S. (20200228). Immunogenicity and safety of a trivalent inactivated influenza vaccine produced in Shenzhen, China versus a comparator influenza vaccine: a phase IV randomized study. : Human vaccines & immunotherapeutics.

Chicago

Hu Yuemei, Chu Kai, Lavis Nathalie, Li Xiaoling, Liang Bill, Liu Shuzhen, Shao Ming, Shu Jean-Denis, Tabar Cynthia and Samson Sandrine. 20200228. Immunogenicity and safety of a trivalent inactivated influenza vaccine produced in Shenzhen, China versus a comparator influenza vaccine: a phase IV randomized study. : Human vaccines & immunotherapeutics.

Harvard

Hu Y., Chu K., Lavis N., Li X., Liang B., Liu S., Shao M., Shu J., Tabar C. and Samson S. (20200228). Immunogenicity and safety of a trivalent inactivated influenza vaccine produced in Shenzhen, China versus a comparator influenza vaccine: a phase IV randomized study. : Human vaccines & immunotherapeutics.

MLA

Hu Yuemei, Chu Kai, Lavis Nathalie, Li Xiaoling, Liang Bill, Liu Shuzhen, Shao Ming, Shu Jean-Denis, Tabar Cynthia and Samson Sandrine. Immunogenicity and safety of a trivalent inactivated influenza vaccine produced in Shenzhen, China versus a comparator influenza vaccine: a phase IV randomized study. : Human vaccines & immunotherapeutics. 20200228.